5Paisa Capital Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 24, 2025, 2:01 pm

Market Cap	1,256 Cr.
Current Price	402
High / Low	607/311
Stock P/E	18.4
Book Value	193
Dividend Yield	0.00 %
ROCE	13.6 %
ROE	11.9 %
Face Value	10.0
PEG Ratio	0.60

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for 5Paisa Capital Ltd

Competitors of 5Paisa Capital Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
MKVentures Capital Ltd	613 Cr.	1,594	2,595/1,151	29.8	267	0.06 %	20.6 %	33.6 %	10.0
Modern Shares & Stockbrokers Ltd	13.6 Cr.	46.4	69.4/36.4	38.8	43.9	0.00 %	4.33 %	3.24 %	10.0
Monarch Networth Capital Ltd	2,450 Cr.	313	501/226	15.8	93.0	0.16 %	51.8 %	43.4 %	10.0
Monotype India Ltd	52.7 Cr.	0.75	2.42/0.66	6.60	0.13	0.00 %	438 %	%	1.00
Multipurpose Trading & Agencies Ltd	5.08 Cr.	10.2	13.3/7.93	26.7	10.2	0.00 %	4.44 %	3.91 %	10.0
Industry Average	6,477.13 Cr	1,387.95		60.23	5,291.52	0.33%	22.28%	17.08%	7.42

All Competitor Stocks of 5Paisa Capital Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	80	88	84	80	84	91	85	97	100	113	102	101	85
Expenses	72	75	66	60	61	65	59	63	70	92	65	62	55
Operating Profit	9	13	18	20	23	25	26	34	30	21	37	38	30
OPM %	11%	15%	21%	25%	27%	28%	30%	35%	30%	18%	36%	38%	35%
Other Income	0	0	0	1	0	1	0	0	0	0	0	0	0
Interest	7	6	5	5	6	5	4	6	8	10	7	6	5
Depreciation	1	2	2	2	2	2	2	2	2	3	3	3	3
Profit before tax	1	6	10	14	15	19	19	25	20	8	27	29	22
Tax %	25%	27%	27%	24%	25%	25%	25%	23%	25%	24%	25%	25%	25%
Net Profit	1	4	7	11	11	14	15	19	15	6	20	22	16
EPS in Rs	0.25	1.50	2.51	3.51	3.60	4.70	4.75	6.19	4.84	1.85	6.44	7.01	5.18

Last Updated: March 3, 2025, 5:48 pm

Below is a detailed analysis of the quarterly data for 5Paisa Capital Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is 85.00 Cr.. The value appears to be declining and may need further review. It has decreased from 101.00 Cr. (Sep 2024) to 85.00 Cr., marking a decrease of 16.00 Cr..
For Expenses, as of Dec 2024, the value is 55.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 62.00 Cr. (Sep 2024) to 55.00 Cr., marking a decrease of 7.00 Cr..
For Operating Profit, as of Dec 2024, the value is 30.00 Cr.. The value appears to be declining and may need further review. It has decreased from 38.00 Cr. (Sep 2024) to 30.00 Cr., marking a decrease of 8.00 Cr..
For OPM %, as of Dec 2024, the value is 35.00%. The value appears to be declining and may need further review. It has decreased from 38.00% (Sep 2024) to 35.00%, marking a decrease of 3.00%.
For Other Income, as of Dec 2024, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
For Interest, as of Dec 2024, the value is 5.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 6.00 Cr. (Sep 2024) to 5.00 Cr., marking a decrease of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 3.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 3.00 Cr..
For Profit before tax, as of Dec 2024, the value is 22.00 Cr.. The value appears to be declining and may need further review. It has decreased from 29.00 Cr. (Sep 2024) to 22.00 Cr., marking a decrease of 7.00 Cr..
For Tax %, as of Dec 2024, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 25.00%.
For Net Profit, as of Dec 2024, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 22.00 Cr. (Sep 2024) to 16.00 Cr., marking a decrease of 6.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 5.18. The value appears to be declining and may need further review. It has decreased from 7.01 (Sep 2024) to 5.18, marking a decrease of 1.83.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 3, 2025, 3:23 pm

Metric	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	7	20	61	108	195	298	338	395	360
Expenses	22	51	78	99	150	251	252	284	233
Operating Profit	-15	-32	-17	10	45	47	87	111	127
OPM %	-199%	-161%	-28%	9%	23%	16%	26%	28%	35%
Other Income	0	0	0	0	0	0	1	0	0
Interest	1	1	7	15	21	23	21	29	24
Depreciation	0	1	1	4	5	5	9	10	12
Profit before tax	-16	-33	-25	-10	20	18	58	72	91
Tax %	-29%	-24%	-25%	-18%	26%	26%	25%	25%	25%
Net Profit	-12	-25	-19	-8	15	14	44	54	68
EPS in Rs	-3.30	-9.92	-7.43	-3.10	5.76	4.67	14.22	17.45	21.84
Dividend Payout %	0%	0%	0%	0%	0%	0%	0%	0%	0%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	-108.33%	24.00%	57.89%	287.50%	-6.67%	214.29%	22.73%	25.93%
Change in YoY Net Profit Growth (%)	0.00%	132.33%	33.89%	229.61%	-294.17%	220.95%	-191.56%	3.20%

5Paisa Capital Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2017-2018 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	%
5 Years:	27%
3 Years:	6%
TTM:	-9%

Compounded Profit Growth
10 Years:	%
5 Years:	60%
3 Years:	71%
TTM:	25%

Stock Price CAGR
10 Years:	%
5 Years:	23%
3 Years:	10%
1 Year:	-25%

Return on Equity
10 Years:	%
5 Years:	10%
3 Years:	11%
Last Year:	12%

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:58 pm

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	13	13	13	25	26	29	31	31	31
Reserves	76	50	32	113	131	345	433	509	572
Borrowings	0	16	92	219	234	279	169	336	217
Other Liabilities	21	52	145	266	477	956	1,009	1,172	846
Total Liabilities	109	131	282	624	867	1,609	1,642	2,048	1,667
Fixed Assets	0	2	2	8	8	11	16	24	20
CWIP	0	0	0	2	0	0	0	0	0
Investments	0	0	3	9	9	14	8	2	2
Other Assets	109	129	277	605	851	1,583	1,618	2,021	1,645
Total Assets	109	131	282	624	867	1,609	1,642	2,048	1,667

Below is a detailed analysis of the balance sheet data for 5Paisa Capital Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 31.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 31.00 Cr..
For Reserves, as of Mar 2025, the value is 572.00 Cr.. The value appears strong and on an upward trend. It has increased from 509.00 Cr. (Mar 2024) to 572.00 Cr., marking an increase of 63.00 Cr..
For Borrowings, as of Mar 2025, the value is 217.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 336.00 Cr. (Mar 2024) to 217.00 Cr., marking a decrease of 119.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 846.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,172.00 Cr. (Mar 2024) to 846.00 Cr., marking a decrease of 326.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 1,667.00 Cr.. The value appears to be improving (decreasing). It has decreased from 2,048.00 Cr. (Mar 2024) to 1,667.00 Cr., marking a decrease of 381.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 24.00 Cr. (Mar 2024) to 20.00 Cr., marking a decrease of 4.00 Cr..
For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Investments, as of Mar 2025, the value is 2.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 2.00 Cr..
For Other Assets, as of Mar 2025, the value is 1,645.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,021.00 Cr. (Mar 2024) to 1,645.00 Cr., marking a decrease of 376.00 Cr..
For Total Assets, as of Mar 2025, the value is 1,667.00 Cr.. The value appears to be declining and may need further review. It has decreased from 2,048.00 Cr. (Mar 2024) to 1,667.00 Cr., marking a decrease of 381.00 Cr..

Notably, the Reserves (572.00 Cr.) exceed the Borrowings (217.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	-21	-51	15	-237	2	-141	25	-92	98
Cash from Investing Activity +	2	-5	1	39	-1	-12	-8	-13	-7
Cash from Financing Activity +	87	-1	27	156	-4	225	-85	154	-141
Net Cash Flow	68	-56	43	-42	-3	73	-68	50	-51

Free Cash Flow

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-15.00	-48.00	-109.00	-209.00	-189.00	-232.00	-82.00	-225.00	-90.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	20	10	12	0	0	0	0	0
Inventory Days
Days Payable
Cash Conversion Cycle	20	10	12	0	0	0	0	0
Working Capital Days	-210	-20	-177	-75	-577	-1,026	-941	-899
ROCE %		-39%	-17%	2%	11%	8%	12%	13%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Jun 2021	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024
Promoters	29.97%	29.96%	29.95%	29.95%	29.94%	32.68%	32.68%	33.33%	33.39%	33.27%	32.84%	32.80%
FIIs	25.05%	25.03%	24.87%	24.86%	24.85%	23.90%	23.89%	23.80%	23.54%	23.08%	22.37%	22.66%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.20%	0.29%
Public	44.98%	45.01%	45.17%	45.19%	45.19%	43.39%	43.40%	42.86%	43.05%	43.63%	44.57%	44.24%
Others	0.00%	0.00%	0.00%	0.00%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%	0.01%
No. of Shareholders	16,554	17,577	17,886	21,475	22,188	24,339	25,005	26,278	27,914	32,049	33,164	42,465

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
DSP Banking & Financial Services Fund	66,069	0.71	3.98	66,069	2025-04-22 17:25:44	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	17.65	14.42	4.72	5.76	-3.39
Diluted EPS (Rs.)	16.67	14.33	4.68	5.73	-3.39
Cash EPS (Rs.)	20.51	17.09	6.38	7.56	-1.59
Book Value[Excl.RevalReserv]/Share (Rs.)	173.09	151.21	127.13	61.17	54.26
Book Value[Incl.RevalReserv]/Share (Rs.)	173.09	151.21	127.13	61.17	54.26
Revenue From Operations / Share (Rs.)	126.50	110.28	100.95	75.61	42.48
PBDIT / Share (Rs.)	35.34	28.57	15.43	17.42	3.65
PBIT / Share (Rs.)	32.28	25.70	13.72	15.62	2.14
PBT / Share (Rs.)	23.12	18.96	6.29	7.80	-3.79
Net Profit / Share (Rs.)	17.45	14.22	4.67	5.76	-3.10
NP After MI And SOA / Share (Rs.)	17.45	14.22	4.67	5.76	-3.10
PBDIT Margin (%)	27.93	25.90	15.28	23.04	8.59
PBIT Margin (%)	25.51	23.30	13.59	20.65	5.04
PBT Margin (%)	18.27	17.19	6.23	10.31	-8.91
Net Profit Margin (%)	13.79	12.89	4.62	7.61	-7.29
NP After MI And SOA Margin (%)	13.79	12.89	4.62	7.61	-7.29
Return on Networth / Equity (%)	10.08	9.40	3.67	9.41	-5.71
Return on Capital Employeed (%)	18.12	16.60	10.56	25.05	3.77
Return On Assets (%)	2.65	2.65	0.85	1.69	-1.26
Total Debt / Equity (X)	0.62	0.36	0.74	1.50	1.59
Asset Turnover Ratio (%)	0.21	0.20	0.23	0.25	0.23
Current Ratio (X)	1.35	1.38	1.28	1.18	1.22
Quick Ratio (X)	1.35	1.38	1.28	1.18	1.22
Interest Coverage Ratio (X)	3.86	4.24	2.08	2.23	0.61
Interest Coverage Ratio (Post Tax) (X)	2.91	3.11	1.63	1.74	0.47
Enterprise Value (Cr.)	271.77	-265.37	93.47	346.91	232.02
EV / Net Operating Revenue (X)	0.68	-0.78	0.31	1.80	2.14
EV / EBITDA (X)	2.47	-3.03	2.06	7.80	24.94
MarketCap / Net Operating Revenue (X)	3.99	2.56	3.42	3.30	2.62
Price / BV (X)	2.91	1.87	2.71	4.08	2.05
Price / Net Operating Revenue (X)	3.99	2.56	3.42	3.30	2.62
EarningsYield	0.03	0.05	0.01	0.02	-0.02

After reviewing the key financial ratios for 5Paisa Capital Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 17.65. This value is within the healthy range. It has increased from 14.42 (Mar 23) to 17.65, marking an increase of 3.23.
For Diluted EPS (Rs.), as of Mar 24, the value is 16.67. This value is within the healthy range. It has increased from 14.33 (Mar 23) to 16.67, marking an increase of 2.34.
For Cash EPS (Rs.), as of Mar 24, the value is 20.51. This value is within the healthy range. It has increased from 17.09 (Mar 23) to 20.51, marking an increase of 3.42.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.09. It has increased from 151.21 (Mar 23) to 173.09, marking an increase of 21.88.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 173.09. It has increased from 151.21 (Mar 23) to 173.09, marking an increase of 21.88.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 126.50. It has increased from 110.28 (Mar 23) to 126.50, marking an increase of 16.22.
For PBDIT / Share (Rs.), as of Mar 24, the value is 35.34. This value is within the healthy range. It has increased from 28.57 (Mar 23) to 35.34, marking an increase of 6.77.
For PBIT / Share (Rs.), as of Mar 24, the value is 32.28. This value is within the healthy range. It has increased from 25.70 (Mar 23) to 32.28, marking an increase of 6.58.
For PBT / Share (Rs.), as of Mar 24, the value is 23.12. This value is within the healthy range. It has increased from 18.96 (Mar 23) to 23.12, marking an increase of 4.16.
For Net Profit / Share (Rs.), as of Mar 24, the value is 17.45. This value is within the healthy range. It has increased from 14.22 (Mar 23) to 17.45, marking an increase of 3.23.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 17.45. This value is within the healthy range. It has increased from 14.22 (Mar 23) to 17.45, marking an increase of 3.23.
For PBDIT Margin (%), as of Mar 24, the value is 27.93. This value is within the healthy range. It has increased from 25.90 (Mar 23) to 27.93, marking an increase of 2.03.
For PBIT Margin (%), as of Mar 24, the value is 25.51. This value exceeds the healthy maximum of 20. It has increased from 23.30 (Mar 23) to 25.51, marking an increase of 2.21.
For PBT Margin (%), as of Mar 24, the value is 18.27. This value is within the healthy range. It has increased from 17.19 (Mar 23) to 18.27, marking an increase of 1.08.
For Net Profit Margin (%), as of Mar 24, the value is 13.79. This value exceeds the healthy maximum of 10. It has increased from 12.89 (Mar 23) to 13.79, marking an increase of 0.90.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 13.79. This value is within the healthy range. It has increased from 12.89 (Mar 23) to 13.79, marking an increase of 0.90.
For Return on Networth / Equity (%), as of Mar 24, the value is 10.08. This value is below the healthy minimum of 15. It has increased from 9.40 (Mar 23) to 10.08, marking an increase of 0.68.
For Return on Capital Employeed (%), as of Mar 24, the value is 18.12. This value is within the healthy range. It has increased from 16.60 (Mar 23) to 18.12, marking an increase of 1.52.
For Return On Assets (%), as of Mar 24, the value is 2.65. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 2.65.
For Total Debt / Equity (X), as of Mar 24, the value is 0.62. This value is within the healthy range. It has increased from 0.36 (Mar 23) to 0.62, marking an increase of 0.26.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.21. It has increased from 0.20 (Mar 23) to 0.21, marking an increase of 0.01.
For Current Ratio (X), as of Mar 24, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.38 (Mar 23) to 1.35, marking a decrease of 0.03.
For Quick Ratio (X), as of Mar 24, the value is 1.35. This value is within the healthy range. It has decreased from 1.38 (Mar 23) to 1.35, marking a decrease of 0.03.
For Interest Coverage Ratio (X), as of Mar 24, the value is 3.86. This value is within the healthy range. It has decreased from 4.24 (Mar 23) to 3.86, marking a decrease of 0.38.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.91. This value is below the healthy minimum of 3. It has decreased from 3.11 (Mar 23) to 2.91, marking a decrease of 0.20.
For Enterprise Value (Cr.), as of Mar 24, the value is 271.77. It has increased from -265.37 (Mar 23) to 271.77, marking an increase of 537.14.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.68. This value is below the healthy minimum of 1. It has increased from -0.78 (Mar 23) to 0.68, marking an increase of 1.46.
For EV / EBITDA (X), as of Mar 24, the value is 2.47. This value is below the healthy minimum of 5. It has increased from -3.03 (Mar 23) to 2.47, marking an increase of 5.50.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 3.99. This value exceeds the healthy maximum of 3. It has increased from 2.56 (Mar 23) to 3.99, marking an increase of 1.43.
For Price / BV (X), as of Mar 24, the value is 2.91. This value is within the healthy range. It has increased from 1.87 (Mar 23) to 2.91, marking an increase of 1.04.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 3.99. This value exceeds the healthy maximum of 3. It has increased from 2.56 (Mar 23) to 3.99, marking an increase of 1.43.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. It has decreased from 0.05 (Mar 23) to 0.03, marking a decrease of 0.02.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of 5Paisa Capital Ltd as of May 24, 2025 is: 344.84

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of May 24, 2025, 5Paisa Capital Ltd is Overvalued by 14.22% compared to the current share price 402.00

Intrinsic Value of 5Paisa Capital Ltd as of May 24, 2025 is: 450.18

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of May 24, 2025, 5Paisa Capital Ltd is Undervalued by 11.99% compared to the current share price 402.00

Last 5 Year EPS CAGR: 30.55%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a low average Working Capital Days of -362.50, which is a positive sign. The company has higher reserves (251.22 cr) compared to borrowings (173.56 cr), indicating strong financial stability. The company has shown consistent growth in sales (198.00 cr) and profit (19.44 cr) over the years.	The stock has a low average ROCE of -1.25%, which may not be favorable. The stock has a high average Cash Conversion Cycle of 5.25, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in 5Paisa Capital Ltd:
1. Net Profit Margin: 13.79%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 18.12% (Industry Average ROCE: 21.98%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 10.08% (Industry Average ROE: 15.58%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 2.91
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 1.35
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 18.4 (Industry average Stock P/E: 44.76)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.62
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

5Paisa Capital Ltd. is a Public Limited Listed company incorporated on 10/07/2007 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L67190MH2007PLC289249 and registration number is 289249. Currently Company is involved in the business activities of Security and commodity contracts brokerage. Company's Total Operating Revenue is Rs. 359.57 Cr. and Equity Capital is Rs. 31.24 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Finance & Investments	IIFL House, Sun Infotech Park, Thane Maharashtra 400604	csteam@5paisa.com http://www.5paisa.com

Management
Name	Position Held
Dr. Archana Niranjan Hingorani	Chairperson & Independent Director
Mr. Gourav Munjal	WholeTime Director & CFO
Mr. Ameya Agnihotri	Whole Time Director
Mr. Milin Mehta	Independent Director
Mr. Ravindra Garikipati	Independent Director
Ms. Nirali Sanghi	Independent Director

FAQ

What is the intrinsic value of 5Paisa Capital Ltd?

5Paisa Capital Ltd's intrinsic value (as of 24 May 2025) is ₹344.84 — 14.22% lower the current market price of 402.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 1,256 Cr. market cap, FY2025-2026 high/low of ₹607/311, reserves of 572 Cr, and liabilities of 1,667 Cr.

What is the Market Cap of 5Paisa Capital Ltd?

The Market Cap of 5Paisa Capital Ltd is 1,256 Cr..

What is the current Stock Price of 5Paisa Capital Ltd as on 24 May 2025?

The current stock price of 5Paisa Capital Ltd as on 24 May 2025 is 402.

What is the High / Low of 5Paisa Capital Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of 5Paisa Capital Ltd stocks is ₹607/311.

What is the Stock P/E of 5Paisa Capital Ltd?

The Stock P/E of 5Paisa Capital Ltd is 18.4.

What is the Book Value of 5Paisa Capital Ltd?

The Book Value of 5Paisa Capital Ltd is 193.

What is the Dividend Yield of 5Paisa Capital Ltd?

The Dividend Yield of 5Paisa Capital Ltd is 0.00 %.

What is the ROCE of 5Paisa Capital Ltd?

The ROCE of 5Paisa Capital Ltd is 13.6 %.

What is the ROE of 5Paisa Capital Ltd?

The ROE of 5Paisa Capital Ltd is 11.9 %.

What is the Face Value of 5Paisa Capital Ltd?

The Face Value of 5Paisa Capital Ltd is 10.0.